http://orcid.org/0000-0001-8416-2733
About the Authors
- Emi Kurimoto
-
Roles Conceptualization, Formal analysis, Investigation, Writing – original draft, Writing – review & editing
Affiliation Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan
- Masato Nakashima
-
Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing
Affiliation Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan
- Haruhide Kimura
-
Roles Conceptualization, Project administration, Writing – review & editing
Affiliation Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan
- Motohisa Suzuki
-
Roles Conceptualization, Formal analysis, Investigation, Supervision, Writing – review & editing
* E-mail: motohisa.suzuki@takeda.com
Affiliation Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan
Competing Interests
We have the following interests. Emi Kurimoto, Masato Nakashima, Haruhide Kimura and Motohisa Suzuki are employed by Takeda Pharmaceutical Company Limited. TAK-071 is currently being clinically evaluated, and there is a patent: WO/2015/163485A1. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.